Please wait



Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)


SCHEDULE 13D/A 0000921895-25-002596 0001776353 XXXXXXXX LIVE 3 Common Stock, $0.001 par value per share 10/20/2025 false 0001621221 04301G607 ARTELO BIOSCIENCES, INC. 505 LOMAS SANTA FE, SUITE 160 SOLANA BEACH CA 92075 RYAN NEBEL 212-451-2300 OLSHAN FROME WOLOSKY LLP 1325 Avenue of the Americas New York NY 10019 0001776353 N Farb Daniel Stuart PF N Z4 16399.00 0.00 16399.00 0.00 16399.00 N 0.8 IN Common Stock, $0.001 par value per share ARTELO BIOSCIENCES, INC. 505 LOMAS SANTA FE, SUITE 160 SOLANA BEACH CA 92075 Item 5(a) is hereby amended and restated to read as follows: The aggregate percentage of Shares reported owned by the Reporting Person is based upon a denominator that is the sum of: (i) 1,555,493 Shares outstanding as of September 16, 2025, as disclosed in the Issuer's Corporate Presentation issued on September 17, 2025 that is available on the Issuer's website, (ii) 441,210 Shares issued pursuant to the Issuer's underwritten offering on October 1, 2025, as disclosed in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on October 1, 2025, and (iii) 11,299 Shares underlying the $10 Warrants (as defined below) held by the Reporting Person. As of the date hereof, the Reporting Person directly beneficially owns 16,399 Shares, including 11,299 Shares underlying the $10 Warrants, as further described below, constituting approximately 0.8% of the Shares outstanding. As of the date hereof, the Reporting Person owns 11,299 warrants referencing 11,299 Shares, which have an exercise price of $10.00 per Share and expire in June 2030 (the "$10 Warrants"). The $10 Warrants are exercisable immediately, subject to the Beneficial Ownership Limitation (as defined below). A holder of the $10 Warrants may not exercise any such $10 Warrants to the extent that such exercise would result in the number of Shares beneficially owned by such holder and his or its affiliates exceeding 4.99% of the total number of Shares outstanding immediately after giving effect to the exercise, except that upon at least 61 days' prior notice from the holder to the Issuer, the holder may increase the beneficial ownership limitation to up to 9.99% of the number of Shares outstanding immediately after giving effect to the exercise (the "Beneficial Ownership Limitation"). The Reporting Person's Beneficial Ownership Limitation is currently set at 4.99%. As of the date hereof, the Beneficial Ownership Limitation does not limit the exercise of any of the 11,299 $10 Warrants owned by the Reporting Person and the Reporting Person may be deemed to beneficially own the 11,299 Shares underlying the 11,299 $10 Warrants. Item 5(c) is hereby amended and restated to read as follows: The transaction in the securities of the Issuer by the Reporting Person since the filing of the Amendment No. 2 to the Schedule 13D are set forth in Exhibit 1 and incorporated herein by reference. Item 5(e) is hereby amended and restated to read as follows: As of October 20, 2025, the Reporting Person ceased to beneficially own more than 5% of the outstanding Shares. Item 7 is hereby amended to add the following exhibit: 1 - Transactions in Securities Farb Daniel Stuart /s/ Daniel S. Farb Daniel S. Farb 10/21/2025